{"id":5592,"date":"2019-06-16T16:29:30","date_gmt":"2019-06-16T14:29:30","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/neue-partner-in-london-und-san-francisco\/"},"modified":"2020-07-03T09:32:41","modified_gmt":"2020-07-03T07:32:41","slug":"neue-partner-in-london-und-san-francisco","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/","title":{"rendered":"SIRION Biotech\u2019s technology supports clinical projects."},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row el_class=&#8221;gco-magazine-container&#8221;][vc_column el_class=&#8221;bildspalte&#8221;][vc_row_inner][vc_column_inner offset=&#8221;vc_col-lg-12 vc_col-md-12&#8243;][vc_column_text el_class=&#8221;gco-magazine&#8211;title&#8221;]SIRION Biotech\u2019s technology supports clinical projects.[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine&#8211;post-date&#8221;]June 2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=&#8221;two-columns&#8221;][vc_column_inner][vc_single_image image=&#8221;5588&#8243; img_size=&#8221;full&#8221;][vc_column_text el_class=&#8221;gco-magazine-copyright-without-description&#8221;]\u00a9 SIRION[\/vc_column_text][vc_single_image image=&#8221;5586&#8243; img_size=&#8221;full&#8221;][vc_column_text el_class=&#8221;gco-magazine-copyright-without-description&#8221;]\u00a9 SIRION[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=&#8221;gco-magazine-container&#8211;copy&#8221;][vc_column_inner][vc_column_text]Our last issue\u2019s headline about SIRION Biotech was labeled \u201cto Paris and Boston\u201d, as we reported on the company\u2019s new branches in two of the Western World\u2019s biggest gene therapy hotspots. Now SIRION Biotech has announced new global development and licensing partnerships with two major gene-therapy players, Orchard Therapeutics in London and Denali Therapeutics in San Francisco.<br \/>\nOrchard Therapeutics developed Strim\u00advelis, the first therapy for ADA-SCID, formerly known as &#8216;bubble-boy disease&#8217;, that was approved in Europe. Denali Therapeutics was founded in 2015 by several former Genentech executives with a focus on neurodegenerative diseases such as Alzheimer&#8217;s, Parkinson&#8217;s and ALS. It gained prominence by accomplishing the largest first venture capital round ever, amounting to 217 million dollar.<br \/>\nFor Orchard, SIRION is helping to improve lentiviral transduction. For Denali, SIRION is developing novel AAV vectors to bridge the blood-brain barrier and target the central-nervous system. Both topics address current technological bottlenecks at the forefront of modern therapy developments.<br \/>\n[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1583761043671{background-color: #1e73be !important;}&#8221; el_class=&#8221;redaktionell&#8221;][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p><span class=\"gco-utils-excerpt\" data-debug-trim-excerpt=\"537\"><span class=\"gco-utils-excerpt__part-xs\">Our last issue\u2019s headline about SIRION Biotech was labeled \u201cto Paris and Boston\u201d, as<\/span><span class=\"gco-utils-excerpt__part-xl\"> we reported on the company\u2019s new branches in two of the Western<\/span><\/span><\/p>\n","protected":false},"author":1,"featured_media":5590,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[286],"tags":[],"class_list":["post-5592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-izb-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>SIRION Biotech\u2019s technology supports clinical projects. - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SIRION Biotech\u2019s technology supports clinical projects.\" \/>\n<meta property=\"og:description\" content=\"Our last issue\u2019s headline about SIRION Biotech was labeled \u201cto Paris and Boston\u201d, as we reported on the company\u2019s new branches in two of the Western World\u2019s biggest gene therapy hotspots. Now SIRION Biotech has announced new global development and licensing partnerships with two major gene-therapy players, Orchard Therapeutics in London and Denali Therapeutics in San Francisco. Orchard Therapeutics developed Strim\u00advelis, the first therapy for ADA-SCID, formerly known as &#039;bubble-boy disease&#039;, that was approved in Europe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-16T14:29:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-03T07:32:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"p534396\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"p534396\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/\"},\"author\":{\"name\":\"p534396\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/12499d818c4e3f59388b94103f0a527e\"},\"headline\":\"SIRION Biotech\u2019s technology supports clinical projects.\",\"datePublished\":\"2019-06-16T14:29:30+00:00\",\"dateModified\":\"2020-07-03T07:32:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/\"},\"wordCount\":315,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg\",\"articleSection\":[\"IZB News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/\",\"name\":\"SIRION Biotech\u2019s technology supports clinical projects. - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg\",\"datePublished\":\"2019-06-16T14:29:30+00:00\",\"dateModified\":\"2020-07-03T07:32:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg\",\"width\":400,\"height\":255,\"caption\":\"San-Francisco-Skyline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/neue-partner-in-london-und-san-francisco\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IZB News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/izb-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"SIRION Biotech\u2019s technology supports clinical projects.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/12499d818c4e3f59388b94103f0a527e\",\"name\":\"p534396\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SIRION Biotech\u2019s technology supports clinical projects. - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/","og_locale":"en_US","og_type":"article","og_title":"SIRION Biotech\u2019s technology supports clinical projects.","og_description":"Our last issue\u2019s headline about SIRION Biotech was labeled \u201cto Paris and Boston\u201d, as we reported on the company\u2019s new branches in two of the Western World\u2019s biggest gene therapy hotspots. Now SIRION Biotech has announced new global development and licensing partnerships with two major gene-therapy players, Orchard Therapeutics in London and Denali Therapeutics in San Francisco. Orchard Therapeutics developed Strim\u00advelis, the first therapy for ADA-SCID, formerly known as 'bubble-boy disease', that was approved in Europe.","og_url":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_published_time":"2019-06-16T14:29:30+00:00","article_modified_time":"2020-07-03T07:32:41+00:00","og_image":[{"width":400,"height":255,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg","type":"image\/jpeg"}],"author":"p534396","twitter_card":"summary_large_image","twitter_misc":{"Written by":"p534396","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#article","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/"},"author":{"name":"p534396","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/12499d818c4e3f59388b94103f0a527e"},"headline":"SIRION Biotech\u2019s technology supports clinical projects.","datePublished":"2019-06-16T14:29:30+00:00","dateModified":"2020-07-03T07:32:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/"},"wordCount":315,"commentCount":0,"publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg","articleSection":["IZB News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/","url":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/","name":"SIRION Biotech\u2019s technology supports clinical projects. - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg","datePublished":"2019-06-16T14:29:30+00:00","dateModified":"2020-07-03T07:32:41+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/IZB-News_Sirion-neue-Partner_San-Francisco_beitragsbild-quer_20191.jpg","width":400,"height":255,"caption":"San-Francisco-Skyline"},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/neue-partner-in-london-und-san-francisco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"IZB News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/izb-news\/"},{"@type":"ListItem","position":4,"name":"SIRION Biotech\u2019s technology supports clinical projects."}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/12499d818c4e3f59388b94103f0a527e","name":"p534396"}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/5592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/comments?post=5592"}],"version-history":[{"count":15,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/5592\/revisions"}],"predecessor-version":[{"id":11635,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/5592\/revisions\/11635"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/5590"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=5592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/categories?post=5592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/tags?post=5592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}